TIA1 and hepatocellular carcinoma: To clarify this issue, we performed immunohistochemistry to evaluate TIA1 protein expression in human tissue microarrays (TMA) of HCC patients (antibody validation: Supplementary Figure S8A; Figure 5A–C, separate analyses see: Supplementary Figure S8B, Supplementary Tables S6–S8).